Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Trump’s pick for HHS secretary has his sights on halting infectious disease research.

While a federal judge has paused the funding cuts, the uncertainty has researchers concerned about the future of scientific ...

Study finds 11% of U.S. adults used dietary supplements for immune support pre-pandemic, emphasizing the importance of ...

Although the funds don’t directly support patient care, they help keep basic operations afloat, such as keeping the lights on ...

The Maine Republican could leverage her position to push back against NIH cuts she opposes. At least for now, the senator is choosing not to.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

The change would cap the maximum "indirect cost rate" research institutions charge the government at 15% of any given grant.

Lawsuit comes after Friday's announcement that the NIH would limit the indirect costs it will pay grantees to 15 percent of a grant.

Rep. Rosa DeLauro warned that limiting grants from the National Institutes of Health will cause “irreparable damage.” ...

NIH's abrupt policy change caps indirect research costs at 15%, sparking debate over its impact on scientific progress and ...

Sen. Susan Collins (R-Maine) slammed the National Institutes of Health’s decision to slash billions of dollars in “indirect” ...